Intravenous immunoglobulin (IVIg) for refractory and difficult-to-treat infections

American Journal of Medicine

Volumn 125, Issue 10, 2012, Pages

  Ferrara, Giovanni ^a,b   Zumla, Alimuddin ^c   Maeurer, Markus ^a,d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF PERUGIA   (Italy)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Clinical use; Difficult to treat infection; Immune response; Intravenous immunoglobulin; Tuberculosis

Indexed keywords

ANTIHISTAMINIC AGENT; DRUG THERAPY; GLUCOCORTICOID; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; NONSTEROID ANTIINFLAMMATORY AGENT; PROCHLORPERAZINE; STEROID;

ACUTE KIDNEY FAILURE; ANAPHYLAXIS; ANEMIA; ANTIGEN PRESENTING CELL; ARTHRALGIA; ARTICLE; ASEPTIC MENINGITIS; ATYPICAL MYCOBACTERIOSIS; AUTOIMMUNE ANEMIA; BACTERIAL INFECTION; CARDIOVASCULAR DISEASE; CELL MATURATION; CHILL; CHRONIC DISEASE; CHRONIC INFLAMMATION; CLINICAL PRACTICE; CLOSTRIDIUM DIFFICILE INFECTION; COMPLICATION; DERMATOMYOSITIS; DERMATOPOLYMYOSITIS; DIFFICULT TO TREAT INFECTION; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG SAFETY; DRUG THERAPY; DRUG TOLERABILITY; ENCEPHALITIS; GUILLAIN BARRE SYNDROME; HUMAN; HYPERTENSION; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE DEFICIENCY; IMMUNOLOGY; INFECTION; INFLAMMATION; KIDNEY FUNCTION; LUNG DISEASE; MEDICAL LITERATURE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIDRUG RESISTANT TUBERCULOSIS; MULTIPLE SCLEROSIS; MYALGIA; NAUSEA; NEUTROPENIA; NOCARDIOSIS; NONHUMAN; PARVOVIRUS INFECTION; PEMPHIGUS; POLYNEUROPATHY; PREVENTION; PRIORITY JOURNAL; RASH; RECURRENT INFECTION; REFRACTORY INFECTION; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS; SIDE EFFECT; SUBSTITUTION THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TUBERCULOSIS; URTICARIA; VIRUS INFECTION; WEST NILE VIRUS ENCEPHALITIS;

BACTERIAL INFECTIONS; CHRONIC DISEASE; COMPLICATIONS; DRUG THERAPY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOLOGY; PREVENTION AND CONTROL; THERAPEUTIC USE; TUBERCULOSIS, MULTIDRUG-RESISTANT; VIRUS DISEASES;

EID: 84866504065     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.01.023     Document Type: Review

References (66)

1. M.D. Kazatchkine, S.V. Kaveri Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin N Engl J Med 345 10 2001 747 755
2. T. Tha-In, H.J. Metselaar, A.R. Bushell, J. Kwekkeboom, K.J. Wood Intravenous Immunoglobulins Promote Skin Allograft Acceptance by Triggering Functional Activation of CD4+Foxp3+ T cells Transplantation 89 12 2010 1446 1455
3. A. Kessel, H. Ammuri, R. Peri Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function J Immunol 179 8 2007 5571 5575
4. T. Tha-In, J. Bayry, H.J. Metselaar, S.V. Kaveri, J. Kwekkeboom Modulation of the cellular immune system by intravenous immunoglobulin Trends Immunol 29 12 2008 608 615
5. F. Nimmerjahn, J.V. Ravetch Anti-inflammatory actions of intravenous immunoglobulin Annu Rev Immunol 26 2008 513 533
6. H.U. Simon, P.J. Späth IVIG - mechanisms of action Allergy 58 7 2003 543 552
7. B. Tackenberg, F. Nimmerjahn, J.D. Lünemann Mechanisms of IVIG efficacy in chronic inflammatory demyelinating polyneuropathy J Clin Immunol 30 Suppl 1 2010 S65 S69
8. Food and Drug Administration Fractionated Plasma Products - Immune Globulin Intravenous (IGIV) Indications http://www.fda.gov/ BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/ FractionatedPlasmaProducts/ucm133691.htm Accessed June 8, 2011
9. A. Cerutti, K. Chen, A. Chorny Immunoglobulin responses at the mucosal interfaces Annu Rev Immunol 29 2011 273 293
10. I. Viard, P. Wehrli, R. Bullani Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin Science 282 5388 1998 490 493
11. D.J. Miller, M. Rodriguez A monoclonal autoantibody that promotes central nervous system remyelination in a model of multiple sclerosis is a natural autoantibody encoded by germline immunoglobulin genes J Immunol 154 5 1995 2460 2469
12. I. Pirko, B. Ciric, J. Gamez A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2-weighted spinal cord MRI in a virus-induced murine model of MS FASEB J 18 13 2004 1577 1579
13. A.E. Warrington, A.J. Bieber, B. Ciric A recombinant human IgM promotes myelin repair after a single, very low dose J Neurosci Res 85 5 2007 967 976
14. F. Gaskin, J. Finley, Q. Fang, S. Xu, S.M. Fu Human antibodies reactive with beta-amyloid protein in Alzheimer's disease J Exp Med 177 4 1993 1181 1186
15. M. Britschgi, C.E. Olin, H.T. Johns Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease Proc Natl Acad Sci U S A 106 29 2009 12145 12150
16. M. Schwartz, Y. Ziv Immunity to self and self-maintenance: a unified theory of brain pathologies Trends Immunol 29 5 2008 211 219
17. M.S. Maddur, J. Vani, P. Hegde Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin J Allergy Clin Immunol 127 3 2011 823 830 e1-e7
18. D.P. Proulx, E. Aubin, R. Lemieux, R. Bazin Spontaneous internalization of IVIg in activated B cells Immunol Lett 124 1 2009 18 26
19. J. Kwekkeboom, T. Tha-In, W.M.W. Tra Hepatitis B immunoglobulins inhibit dendritic cells and T cells and protect against acute rejection after liver transplantation Am J Transplant 5 10 2005 2393 2402
20. J. Bayry, S. Lacroix-Desmazes, C. Carbonneil Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin Blood 101 2 2003 758 765
21. J. Siegel Safety considerations in IGIV utilization Int Immunopharmacol 6 4 2006 523 527
22. M. Ballow Immunoglobulin therapy: methods of delivery J Allergy Clin Immunol 122 5 2008 1038 1039
23. I. Quinti, A. Soresina, G. Spadaro Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency J Clin Immunol 27 3 2007 308 316
24. U. Katz, I. Kishner, D. Magalashvili, Y. Shoenfeld, A. Achiron Long term safety of IVIg therapy in multiple sclerosis: 10 years experience Autoimmunity 39 6 2006 513 517
25. N. Shehata, V. Palda, T. Bowen The use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guideline Transfus Med Rev 24 Suppl 1 2010 S28 S50
26. J.S. Orange, W.J. Grossman, R.J. Navickis, M.M. Wilkes Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies Clin Immunol 137 1 2010 21 30
27. P. Quartier, M. Debré, J. De Blic Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients J Pediatr 134 5 1999 589 596
28. L.M. Mofenson, J. Moye, J. Bethel Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 × 10(9)/L or more Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group jama 268 4 1992 483 488
29. S.A. Spector, R.D. Gelber, N. McGrath A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection Pediatric aidsClinical Trials Group N Engl J Med 331 18 1994 1181 1187
30. M. Garcia-Lloret, S. McGhee, T.A. Chatila Immunoglobulin replacement therapy in children Immunol Allergy Clin North Am 28 4 2008 833 849 ix
31. D. Pastori, A. Esposito, I. Mezzaroma Immunomodulatory effects of intravenous immunoglobulins (IVIGs) in HIV-1 disease: a systematic review Int Rev Immunol 30 1 2011 44 66
32. A. Lindkvist, A. Edén, M.M. Norström Reduction of the HIV-1 reservoir in resting CD4+ T-lymphocytes by high dosage intravenous immunoglobulin treatment: a proof-of-concept study aids Res Ther 6 2009 15
33. P. Raanani, A. Gafter-Gvili, M. Paul Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: systematic review and meta-analysis J Clin Oncol 27 5 2009 770 781
34. D. Engelhard, M. Akova, M.J. Boeckh Bacterial infection prevention after hematopoietic cell transplantation Bone Marrow Transplant 44 8 2009 467 470
35. J.L. Wynn, P.C. Seed, C.M. Cotten Does IVIg administration yield improved immune function in very premature neonates? J Perinatol 30 10 2010 635 642
36. A.F. Turgeon, B. Hutton, D.A. Fergusson Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis Ann Intern Med 146 3 2007 193 203
37. S. Izdes, N.D. Altintas, A. Eldem, H. Ceyhan, O. Kanbak Intravenous polyclonal IgM-enriched immunoglobulin therapy for resistant Acinetobacter sepsis in a pregnant patient with ARDS due to H1N1 infection Int J Obstet Anesth 20 1 2011 99 100
38. A. Ohlsson, J. Lacy Intravenous immunoglobulin for suspected or subsequently proven infection in neonates Cochrane Database Syst Rev 3 2010 CD001239
39. S.S. Shah, M. Hall, R. Srivastava, A. Subramony, J.E. Levin Intravenous immunoglobulin in children with streptococcal toxic shock syndrome Clin Infect Dis 49 9 2009 1369 1376
40. T.D. van Immerzeel, R.M. van Gilst, N.G. Hartwig Beneficial use of immunoglobulins in the treatment of Sydenham chorea Eur J Pediatr 169 9 2010 1151 1154
41. C.A. Kirvan, C.J. Cox, S.E. Swedo, M.W. Cunningham Tubulin is a neuronal target of autoantibodies in Sydenham's chorea J. Immunol 178 11 2007 7412 7421
42. M.G. Fehlings, D.H. Nguyen Immunoglobulin G: a potential treatment to attenuate neuroinflammation following spinal cord injury J Clin Immunol 30 Suppl 1 2010 S109 S112
43. R.J. Charles, K.M. Sabo, P.G. Kidd, J.L. Abkowitz The pathophysiology of pure red cell aplasia: implications for therapy Blood 87 11 1996 4831 4838
44. K. Sawada, N. Fujishima, M. Hirokawa Acquired pure red cell aplasia: updated review of treatment Br J Haematol 142 4 2008 505 514
45. R. Dennert, S. Velthuis, S. Schalla Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load Antivir Ther (Lond.) 15 2 2010 193 201
46. B. Makhoul, E. Braun, M. Herskovitz Hyperimmune gammaglobulin for the treatment of West Nile virus encephalitis Isr Med Assoc J 11 3 2009 151 153
47. Y. Hofmeister, C.B. Planitzer, M.R. Farcet Human IgG subclasses: in vitro neutralization of and in vivo protection against West Nile virus J Virol 85 4 2011 1896 1899
48. E. Whimbey, R.E. Champlin, J.A. Englund Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients Bone Marrow Transplant 16 3 1995 393 399
49. X. Shen, G.D. Tomaras Alterations of the B-cell response by HIV-1 replication Curr HIV/aids Rep 8 1 2011 23 30
50. A. Abdollahi, A. Morteza Serum concentrations of antiphospholipid and anticardiolipin antibodies are higher in HIV-infected women Rheumatol Int 2011 Mar 30 [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/21448646 Accessed June 14, 2011
51. D.K.M. Muema, F.M. Ndungu, S.M. Kinyanjui, J.A. Berkley Effect of HIV infection on the acute antibody response to malaria antigens in children: an observational study Malar J 10 2011 55
52. H. Singh, K.A. Henry, S.S. Wu Reactivity profiles of broadly neutralizing anti-HIV-1 antibodies are distinct from those of pathogenic autoantibodies aids 25 10 2011 1247 1257
53. L. Lopalco Natural anti-CCR5 antibodies in HIV-infection and -exposure J Transl Med 9 Suppl 1 2011 S4
54. T. Koya, C. Tsubata, H. Kagamu Anti-interferon-gamma autoantibody in a patient with disseminated Mycobacterium avium complex J Infect Chemother 15 2 2009 118 122
55. C. Höflich, R. Sabat, S. Rosseau Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans Blood 103 2 2004 673 675
56. S. McPherson, C.J. Rees, R. Ellis, S. Soo, S.J. Panter Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea Dis Colon Rectum 49 5 2006 640 645
57. D.J. Hamrock Adverse events associated with intravenous immunoglobulin therapy Int Immunopharmacol 6 4 2006 535 542
58. P. Camus, A. Fanton, P. Bonniaud, C. Camus, P. Foucher Interstitial lung disease induced by drugs and radiation Respiration 71 4 2004 301 326
59. D.B. Flieder, W.D. Travis Pathologic characteristics of drug-induced lung disease Clin Chest Med 25 1 2004 37 45
60. F. Abebe, G. Bjune The protective role of antibody responses during Mycobacterium tuberculosis infection Clin Exp Immunol 157 2 2009 235 243
61. H.-C. Huang, W.-L. Yu, C.-C. Shieh, K.-C. Cheng, H.-H. Cheng Unusual mixed infection of thoracic empyema caused by Mycobacteria tuberculosis, nontuberculosis mycobacteria and Nocardia asteroides in a woman with systemic lupus erythematosus J Infect 54 1 2007 e25 e28
62. World Health Organization Global tuberculosis control 2010 http://www.who.int/tb/publications/global-report/2010/en/ Accessed June 23, 2011
63. K. Dheda, K. Shean, A. Zumla Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study Lancet 375 9728 2010 1798 1807
64. Department of Health Clinical guidelines for immunoglobulin use (second edition) http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH-085235 Accessed June 8, 2011
65. National Blood Authority NBA: Criteria for the Clinical Use of Intravenous Immunoglobulin (IVIg) http://www.nba.gov.au/ivig/review.html Accessed June 8, 2011
66. J.N. Shah, R.F. Chemaly Management of RSV infections in adult recipients of hematopoietic stem cell transplantation Blood 117 10 2011 2755 2763